Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Agilent Technologies, Inc. (A) Cash Flow Statement

Agilent Technologies, Inc. (A) generated $1.6B of operating cash flow over the twelve months to 2026-07-31, spent $342.0M on capital expenditure and had free cash flow of $1.3B, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

AAgilent Technologies, Inc.Follow A — free
Diagnostics & Research · Healthcare
—
Price chart with a free account
Market cap
48.8B
P/E TTM
34.1
Dividend yield
0.6%
52-week
—
Next earnings
23 Nov, in 30 days
LineFY2009
Oct 09
FY2010
Oct 10
FY2011
Oct 11
FY2012
Oct 12
FY2013
Oct 13
FY2014
Oct 14
FY2015
Oct 15
FY2016
Oct 16
FY2017
Oct 17
FY2018
Oct 18
FY2019
Oct 19
FY2020
Oct 20
FY2021
Oct 21
FY2022
Oct 22
FY2023
Oct 23
FY2024
Oct 24
FY2025
Oct 25
TTM
Jul 26
Trend
Operating cash flow0.410.721.261.231.150.730.510.790.891.091.020.921.491.311.771.751.561.61
Capital expenditure0.130.120.190.190.200.210.100.140.180.180.160.120.190.290.300.380.41-0.34
Free cash flow0.280.601.071.030.960.530.410.650.710.910.870.801.301.021.471.371.151.27
Dividends paid———0.100.160.180.130.150.170.190.210.220.240.250.270.270.28—
Share repurchases0.160.410.500.170.900.200.270.430.190.420.720.470.791.140.581.150.43—
Stock-based compensation0.070.070.070.070.090.100.050.060.060.070.070.080.110.130.110.130.13—

USD billions · SEC XBRL

Agilent Technologies, Inc. — questions

What is Agilent Technologies, Inc.'s operating cash flow?
$1.6B over the twelve months to 2026-07-31.
How much does Agilent Technologies, Inc. spend on capital expenditure?
$342.0M over the twelve months to 2026-07-31.
What is Agilent Technologies, Inc.'s free cash flow?
$1.3B over the twelve months to 2026-07-31: operating cash flow minus capital expenditure.

Every figure on this page comes from Agilent Technologies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.